Currently, there are 320.42M common shares owned by the public and among those 88.74M shares have been available to trade.
The company’s stock has a 5-day price change of 5.88% and -20.75% over the past three months. ADV shares are trading -13.70% year to date (YTD), with the 12-month market performance down to -31.52% lower. It has a 12-month low price of $2.22 and touched a high of $4.95 over the same period. ADV has an average intraday trading volume of 438.10K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.58%, -20.46%, and -27.88% respectively.
Institutional ownership of Advantage Solutions Inc (NASDAQ: ADV) shares accounts for 21.51% of the company’s 320.42M shares outstanding.
It has a market capitalization of $808.30M and a beta (3y monthly) value of 1.63. The earnings-per-share (ttm) stands at -$0.71. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.87% over the week and 5.39% over the month.
Analysts forecast that Advantage Solutions Inc (ADV) will achieve an EPS of 0.12 for the current quarter, 0.09 for the next quarter and 0.46 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.12 while analysts give the company a high EPS estimate of 0.12. Comparatively, EPS for the current quarter was 0.06 a year ago. Earnings per share for the fiscal year are expected to increase by 277.73%, and 40.91% over the next financial year.
Looking at the support for the ADV, a number of firms have released research notes about the stock. Canaccord Genuity stated their Buy rating for the stock in a research note on December 06, 2023, with the firm’s price target at $4. Morgan Stanley coverage for the Advantage Solutions Inc (ADV) stock in a research note released on May 11, 2023 offered a Equal-Weight rating with a price target of $3. Deutsche Bank was of a view on March 30, 2022 that the stock is Hold, while Goldman gave the stock Neutral rating on March 04, 2022, issuing a price target of $12- $7. Morgan Stanley on their part issued Equal-Weight rating on April 01, 2021.
